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Abstract
Cardiovascular disease is the primary cause of death in Brazil. Recent
studies have shown that low birth weight and preterm birth are linked
to a higher prevalence of cardiovascular disease. The aim of the
present study was to compare the levels of lipids and apolipoproteins
and atherogenic indexes between term and near-term newborn infants.
A sample of umbilical cord blood was obtained from 135 newborns
(66 males) divided into two groups: 25 near-term neonates (35-36.6
weeks of gestational age) and 110 term neonates (37-42 weeks of
gestational age). The total cholesterol concentrations were higher in
the near-term neonates than in the term group (94.04 ± 8.02 vs 70.42
± 1.63 mg/dl, P < 0.01), due to an increase in the LDL-cholesterol
fraction in the near-term group (57.76 ± 6.39 vs 34.38 ± 1.29 mg/dl, P
< 0.001). The atherogenic indexes (total cholesterol/HDL-cholesterol,
LDL-cholesterol/HDL-cholesterol and apolipoprotein B/apolipopro-
tein A-I) were higher in the near-term group (P < 0.001, P < 0.001, and
P < 0.05, respectively). The gestational age of the newborns was
inversely correlated with total cholesterol and LDL-cholesterol, and
also with the total cholesterol/HDL-cholesterol and LDL-cholesterol/
HDL-cholesterol indexes. These findings demonstrate that the lipid
profile is worse in the group of near-term neonates compared with the
term group. Future studies are needed to determine if this atherogenic
profile in near-term neonates can affect body metabolism, increasing
the risk for cardiovascular diseases in adult life.
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Introduction
Cardiovascular disease is the primary
cause of death in developed countries, as
well as in Brazil and other Latin American
countries (1). The incidence of coronary ar-
tery disease depends, in general, on the preva-
lence of genetic and environmental risk fac-
tors. Recent animal experiments and human
studies have shown the influence of the in-
trauterine environment on the development
of risk factors for cardiovascular disease (2).
Thus, the arterial hypertension of adults and
the changes it causes in plasma levels of
fibrinogen, total cholesterol and LDL-cho-
lesterol start during fetal life and are associ-
ated with fetal growth restriction and low
birth weight (3). The primary prevention of
756
Braz J Med Biol Res 38(5) 2005
I.M.C.G. Pardo et al.
hypertension may depend on strategies that
promote fetal growth (4).
It is known that premature newborns have
lost the chance to complete their energy
deposits. Thus, many times the preterm neo-
nate needs to use these endogenous reserves,
basically activating lipid metabolism that
generates energy and promotes gluconeo-
genesis (5). The long-term consequences of
these metabolic adaptations have not been
elucidated. Barker et al. (6) demonstrated
that low birth weight correlated with an in-
creased prevalence of cardiovascular dis-
ease, hypertension and type 2 diabetes melli-
tus. These investigators suggested that this
association reflects the phenomenon known
as programming, whereby a stimulation or
insult during a critical period of intrauterine
life could also result in alterations of physi-
ology and metabolism during adult life (7).
Apolipoprotein A-I, apolipoprotein B and
the apolipoprotein B/apolipoprotein A-I ra-
tio are considered to be markers of cardio-
vascular disease risk. Recent studies demon-
strated that the detection of these markers in
umbilical cord blood from term newborns
could identify neonates at a higher risk for
coronary heart disease (8,9).
The aim of the present study was to com-
pare the levels of lipids and apolipoproteins
in umbilical blood cord, as well as the athero-
genic indexes of term and near-term neo-
nates.
Patients and Methods
We collected umbilical cord blood im-
mediately after birth from 135 newborns (66
males) divided into two groups: 25 near-
term neonates (35-36.6 weeks of gestational
age) and 110 term neonates (37-42 weeks of
gestational age). The sample size was calcu-
lated on the basis of Campoy Folgoso et al.
(5). Ninety-six samples were considered to
be the minimal number required for the pres-
ent study. Values of α and ß were estab-
lished at 0.05 and 0.10, respectively.
The newborns were selected according
to the following criteria: birth weight appro-
priate for gestational age, gestational age
between 35-42 weeks, one-minute Apgar
score >7, absence of congenital anomalies,
singleton pregnancies, and absence of ma-
ternal diseases such as hypertension, diabe-
tes mellitus, thyroid diseases, or hypercho-
lesterolemia. None of the mothers was tak-
ing any medication, except for vitamin and
iron supplements during pregnancy. A pre-
viously tested maternal questionnaire was
applied by one researcher in order to obtain
maternal clinical data and information about
family heart diseases. The weight and height
of all pregnant women were measured and
the body mass index (kg/m²) was calculated.
Maternal weight gain during pregnancy was
recorded. The weight, length and head cir-
cumference of all neonates were measured
immediately after delivery. The newborns’
weight was determined using a portable scale
and length was measured using an appropri-
ate stadiometer. Gestational age was calcu-
lated from the date of the last menstruation
and confirmed by ultrasound measurement.
Umbilical venous blood was obtained at
the time of delivery immediately after cord
clamping and centrifuged. Serum was sepa-
rated and used for the determination of total
cholesterol, LDL-cholesterol and HDL-cho-
lesterol by standard enzymatic methods (10).
Apolipoprotein A-I and apolipoprotein B
were measured by nephelometry (11). The
following atherogenic indexes were calcu-
lated: total cholesterol/HDL-cholesterol,
LDL-cholesterol/HDL-cholesterol and apo-
lipoprotein B/apolipoprotein A-I.
The study was carried out in accordance
with the current revision of the Helsinki
Declaration and with Brazilian resolution
196/96. The study protocol was approved by
the local Ethics Committee and written in-
formed consent was obtained from all moth-
ers.
Data are reported as means ± SEM. Dif-
ferences between groups were evaluated by
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the Mann-Whitney test. Spearman rank co-
efficients were used to determine relation-
ships between continuous variables. A P
value of less than 0.05 was considered to be
significant. The SPSS Program version 7.5
was used for all statistical calculations.
Results
The clinical characteristics of the moth-
ers of the newborns are described in Table 1.
Maternal age, prepregnancy weight and
weight gain during pregnancy were higher in
the group who delivered at term than in the
group that delivered at near-term (P = 0.004,
P = 0.045, and P < 0.045, respectively). A
positive family history (dyslipidemia and or
heart disease) was found in 28 (25.45%) of
the term group and in 6 (24%) of the near-
term group, with no significant difference
between groups.
The characteristics of the near-term and
term neonates are presented in Table 2. The
near-term group had significantly lower birth
weight, birth length and head circumference
than the term group. No gender differences
were found in cord blood total cholesterol,
HDL-cholesterol, LDL-cholesterol, apolip-
oprotein A-I, apolipoprotein B, or athero-
genic indexes (total cholesterol/HDL-cho-
lesterol, LDL-cholesterol/HDL-cholesterol
and apolipoprotein B/apolipoprotein A-I in-
dexes). Therefore, the data were not strati-
fied for gender.
The near-term neonate group presented a
clearly different lipid profile compared to
the term group, as described in Table 3. The
total cholesterol concentrations were higher
in the near-term group than in the term group
(94.04 ± 8.02 vs 70.42 ± 1.63 mg/dl, P <
0.001). The near-term group basically pre-
sented an increased LDL fraction compared
to the term group (57.76 ± 6.39 vs 34.38 ±
1.29 mg/dl, P < 0.001). The total cholesterol/
HDL-cholesterol, LDL-cholesterol/HDL-
cholesterol and apolipoprotein B/apolipo-
protein A-I indexes were higher in the near-
Table 1. Clinical characteristics of the mothers.
Term neonates Near-term
(N = 110) neonates (N = 25)
Age (years) 25.13 ± 0.60 21.56 ± 1.20*
Weight (kg) 60.35 ± 1.22 55.36 ± 1.96*
Height (cm) 159.67 ± 0.66 159.20 ± 1.67
BMI 23.66 ± 0.45 21.76 ± 0.55
Weight gain (kg) 11.95 ± 0.38 10.91 ± 0.98*
Data are reported as means ± SEM. BMI = body mass index.
*P < 0.05 compared to term neonates (Mann-Whitney test).
Table 2. Characteristics of the newborns.
Term neonates Near-term
(N = 110) neonates (N = 25)
Males/females (N) 51/59 15/10
Birth weight (g) 3181 ± 26.99 2402 ± 71.62*
Birth length (cm) 48.41 ± 0.14 44.58 ± 0.48*
Gestational age (weeks) 39.18 ± 0.12 35.57 ± 0.11*
Head circumference (cm) 34.24 ± 0.13 32.02 ± 0.32*
Data are reported as means ± SEM.
*P < 0.05 compared to term neonates (Mann-Whitney test).
term group (P < 0.001, P < 0.001, P < 0.05,
respectively) compared to the term group.
Although the concentrations of apolipopro-
tein A-I and apolipoprotein B were not sig-
nificantly different, we observed a trend to-
wards a worse lipid profile in the near-term
group, with lower apolipoprotein A-I levels
Table 3. Lipids, apolipoproteins and atherogenic indexes of the
newborn umbilical cord blood.
Term neonates Near-term
(N = 110) neonates (N = 25)
Total cholesterol (mg/dl) 70.42 ± 1.63 94.04 ± 8.02*
HDL-C (mg/dl) 26.75 ± 0.65 28.84 ± 1.85
LDL-C (mg/dl) 34.38 ± 1.29 57.76 ± 6.39*
Total cholesterol/HDL-C 2.71 ± 0.06 3.26 ± 0.13*
LDL-C/HDL-C 1.35 ± 0.05 1.97 ± 0.12*
Apo A-I (ng/dl) 91.08 ± 2.20 89.00 ± 5.48
Apo B (ng/dl) 43.36 ± 1.71 56.84 ± 7.55
Apo B/Apo A-I 0.51 ± 0.03 0.67 ± 0.09*
Data are reported as means ± SEM. C = cholesterol; Apo =
apolipoprotein.
*P < 0.05 compared to term neonates (Mann-Whitney test).
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(89.00 ± 5.48 vs 91.08 ± 2.20 ng/dl) and
higher apolipoprotein B levels than in the
term neonate group (56.84 ± 7.55 vs 43.36 ±
1.71 ng/dl).
The gestational age of all 135 newborns
correlated inversely with total cholesterol
(r = -0.256, P < 0.01), LDL-cholesterol
(r = -0.369, P < 0.01), total cholesterol/HDL-
cholesterol index (r = -0.254, P < 0.01) and
also with LDL-cholesterol /HDL-cholesterol
index (r = -0.351, P < 0.01) (Table 4).
Discussion
The cholesterol levels detected in um-
bilical cord blood were lower than those
found in plasma of adults. Since total choles-
terol increases after birth, it might be pre-
sumed that the total cholesterol levels of
preterm neonates are similar to or lower than
those observed in term infants. However,
our results demonstrated that the cholesterol
levels of the premature group were substan-
tially higher than those of the term group, in
agreement with a previous report (12). More-
over, our study indicates that this difference
exists even though the premature neonates
were near term, with a gestational age of 35-
36.6 weeks.
It has been reported that the plasma de-
pletion of cholesterol that occurs at term is
due to a decrease in HDL-cholesterol and
LDL-cholesterol levels. Probably the cause
of the fall in plasma LDL-cholesterol con-
centration is explained by the increase of its
uptake by the fetal adrenal gland for steroid
hormone production, as postulated by Parker
Jr. et al. (13). Since HDL-cholesterol is not
metabolized efficiently by the adrenals, the
fall in HDL-cholesterol levels may be asso-
ciated with an increase in the activity of the
lectin acetyl cholesterol transferase enzyme.
Spear et al. (14) demonstrated that lectin
acetyl cholesterol transferase activity was
lower in near-term neonates compared with
the term infants. However, we found that the
decrease of total cholesterol was due to LDL-
cholesterol, whereas HDL-cholesterol re-
mained constant. This finding is in agree-
ment with the results of Parker Jr. et al. (15),
but in conflict with the results of Spear et al.
(14). This discrepancy might be explained
by the group selected for study (very near
term) or by differences in the design of the
studies. Although the concentrations of apo-
lipoprotein A-I and apolipoprotein B were
not significantly different, our findings show
a trend towards a worse lipid profile in the
near-term group, with higher apolipoprotein
B levels, related to low-density lipoproteins,
and lower apolipoprotein A-I levels, related
to the inverse cholesterol transport, that pro-
tect against atherosclerotic lesions. More-
over the apolipoprotein B/apolipoprotein A-
I index, considered to be one of the best
markers of risk for cardiovascular disease
even during the first year of life (16), was
significantly higher in the near-term neonate
group compared with the term group, dem-
onstrating that this index is altered even in
umbilical blood cord. Future studies could
elucidate the reasons and the consequences
of these differences between near-term and
term neonates.
The gestational age of the newborns cor-
related inversely with total cholesterol, LDL-
cholesterol, and total cholesterol/HDL-cho-
lesterol and LDL-cholesterol/HDL-choles-
terol index, confirming the difference in li-
pid distribution between preterm and term
Table 4. Correlation coefficients between lipid profile and gestational age of 135
newborns.
Correlation coefficient
Gestational age versus Apo A-I 0.054
Gestational age versus Apo B -0.141
Gestational age versus total cholesterol* -0.256
Gestational age versus HDL-C -0.038
Gestational age versus LDL-C* -0.369
Gestational age versus Apo B/Apo A-I -0.081
Gestational age versus total cholesterol/HDL-C* -0.254
Gestational age versus LDL-C/HDL-C* -0.351
C = cholesterol; Apo = apolipoprotein.
*P < 0.01 for Spearman rank correlation.
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infants. Preterm birth (17) and low birth
weight (18) have been described as factors
for cardiovascular risk in adult life. The
long-term consequences of the hypercholes-
terolemic ambient seen in premature new-
borns regarding fatty streak formation are
still debated. Although the atherogenic pro-
cess has been recognized as a pediatric prob-
lem since 1965, the reversibility of the inju-
ries in this early phase of life is highly ques-
tionable. Napoli et al. (19) described aortic
fatty streak formation in human fetuses, prob-
ably enhanced by maternal and presumably
fetal hypercholesterolemia. A new study
published by the same authors (20) demon-
strated the existence of lipid accumulation in
the extracranial arteries of aborted fetuses
and preterm newborns, demonstrating the
atherogenic response to a hypercholestero-
lemic environment. A twin study suggested
that genetic factors account for the associa-
tion of low birth weight with high levels of
total cholesterol, LDL-cholesterol and apo-
lipoprotein B (21). A recent study correlated
low gestational age with abnormal retinal
vascularization and increased blood pres-
sure in adult women (22).
 The results of the present study indicate
the necessity for further research to deter-
mine if an adverse lipid profile can affect
body metabolism, increasing the risk for fu-
ture complications. This fact acquires a very
important impact when we observe the high
incidence of cesarean sections in Brazil, up
to 81.8% in private hospitals (23), which are
associated with low birth weight and preterm
birth (24), reflecting often abusive indica-
tions for such procedure. A study carried out
in Southeast Brazil described cesarean sec-
tion as the main contributor to the increase in
preterm birth rate (25), suggesting the need
for reorientation in neonatal health care. Since
we found changes in lipid profile in near-
term newborns, we speculate that the abu-
sive indications of cesarean section for near-
term newborns with a birth weight of 2000-
2500 g could be a harmful decision with
metabolic consequences in later life. Re-
search aimed at elucidating this proposition
offers an important challenge to transform
this situation.
Our findings demonstrate that total cho-
lesterol, LDL-cholesterol fraction and athero-
genic indexes are significantly higher in near-
term neonates compared with term infants,
showing a trend to a worse lipid profile in
Brazilian near-term infants. Future studies
are needed to determine if this atherogenic
profile in near-term neonates can affect body
metabolism, increasing the risk for cardio-
vascular diseases in adult life.
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